217 related articles for article (PubMed ID: 1542259)
21. Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.
Maor I; Hayek T; Coleman R; Aviram M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2995-3005. PubMed ID: 9409286
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation.
Keidar S; Kaplan M; Aviram M
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):97-105. PubMed ID: 8548433
[TBL] [Abstract][Full Text] [Related]
23. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
24. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake.
Kaplan M; Aviram M
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):386-93. PubMed ID: 11231918
[TBL] [Abstract][Full Text] [Related]
25. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
[TBL] [Abstract][Full Text] [Related]
26. In vitro oxidised HDL exerts a cytotoxic effect on macrophages.
Hurtado I; Fiol C; Gracia V; Caldú P
Atherosclerosis; 1996 Aug; 125(1):39-46. PubMed ID: 8831925
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
Hanna AN; Feller DR; Witiak DT; Newman HA
Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
[TBL] [Abstract][Full Text] [Related]
28. Reconstituted high density lipoprotein reduces the capacity of oxidatively modified low density lipoprotein to accumulate cholesteryl esters in mouse peritoneal macrophages.
Sakai M; Miyazaki A; Hakamata H; Suginohara Y; Sakamoto YI; Morikawa W; Kobori S; Schichiri M; Horiuchi S
Atherosclerosis; 1996 Jan; 119(2):191-202. PubMed ID: 8808496
[TBL] [Abstract][Full Text] [Related]
29. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein.
Sakai M; Kobori S; Matsumura T; Biwa T; Sato Y; Takemura T; Hakamata H; Horiuchi S; Shichiri M
Atherosclerosis; 1997 Aug; 133(1):51-9. PubMed ID: 9258407
[TBL] [Abstract][Full Text] [Related]
30. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
[TBL] [Abstract][Full Text] [Related]
31. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
Helve E; Tikkanen MJ
Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
[TBL] [Abstract][Full Text] [Related]
33. The contribution of the macrophage receptor for oxidized LDL to its cellular uptake.
Aviram M
Biochem Biophys Res Commun; 1991 Aug; 179(1):359-65. PubMed ID: 1883365
[TBL] [Abstract][Full Text] [Related]
34. Lipoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation.
Liu SX; Zhou M; Chen Y; Wen WY; Sun MJ
Atherosclerosis; 1996 Mar; 121(1):55-61. PubMed ID: 8678924
[TBL] [Abstract][Full Text] [Related]
35. In vitro oxidised HDL is recognized by the scavenger receptor of macrophages: implications for its protective role in vivo.
La Ville AE; Sola R; Balanya J; Turner PR; Masana L
Atherosclerosis; 1994 Feb; 105(2):179-89. PubMed ID: 8003094
[TBL] [Abstract][Full Text] [Related]
36. Differences in the metabolism of oxidatively modified low density lipoprotein and acetylated low density lipoprotein by human endothelial cells: inhibition of cholesterol esterification by oxidatively modified low density lipoprotein.
Jialal I; Chait A
J Lipid Res; 1989 Oct; 30(10):1561-8. PubMed ID: 2614259
[TBL] [Abstract][Full Text] [Related]
37. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover.
Uauy R; Vega GL; Grundy SM; Bilheimer DM
J Pediatr; 1988 Aug; 113(2):387-92. PubMed ID: 3397806
[TBL] [Abstract][Full Text] [Related]
38. Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages.
Kempen HJ; Vermeer M; de Wit E; Havekes LM
Arterioscler Thromb; 1991; 11(1):146-53. PubMed ID: 1987992
[TBL] [Abstract][Full Text] [Related]
39. Red wine inhibits the cell-mediated oxidation of LDL and HDL.
Rifici VA; Stephan EM; Schneider SH; Khachadurian AK
J Am Coll Nutr; 1999 Apr; 18(2):137-43. PubMed ID: 10204829
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages.
Hendriks WL; van der Boom H; van Vark LC; Havekes LM
Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):563-8. PubMed ID: 8670071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
